Progyny, Inc.
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
a. None.
b. None.
c. During the three months ended September 30, 2025, certain of our officers and directors adopted orterminated Rule 10b5-1 trading arrangements as follows:
On August 15, 2025, Mark Livingston, our Chief Financial Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Livingston’s trading plan is for the sale of up to 42,938 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or August 14, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.